We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The effect of subclinic thyroid pathologies on erythropoietine dose in hemodialysis patients.
- Authors
Onan, Engin; Yasar, Mehmet; Soysal, Busra; Paydas, Saime
- Abstract
Purpose: The effect of subclinical thyroid pathologies on erythropoietin (EPO) treatment has not been well defined. The aim of the study is to compare the frequency and dose of EPO administration in patients with subclinical thyroid pathology and euthyroid hemodialysis patients. Methods: A cross‐sectional and retrospective study was conducted with 210 patients. Special conditions were excluded, a total of 191 patients were included. Patients were divided into three groups. Results: The incidences of subclinical hypothyroidism, subclinical hyperthyroidism and euthyroidism were 10.5%, 3.1%, and 86.4%, respectively. Statistically significant difference was found between subclinical hypothyroid and euthyroid patients in terms of the number of patients using EPO (p = 0.0207), monthly total EPO doses (p = 0.003), and total monthly EPO doses per weight (p = 0.001). Conclusion: The EPO dose required to achieve similar hemoglobin levels in hemodialysis patients was significantly higher in subclinical hypothyroid patients than in euthyroid patients.
- Subjects
HEMODIALYSIS patients; HYPOTHYROIDISM; THYROID gland; ERYTHROPOIETIN; PATHOLOGY
- Publication
Therapeutic Apheresis & Dialysis, 2023, Vol 27, Issue 3, p587
- ISSN
1744-9979
- Publication type
Academic Journal
- DOI
10.1111/1744-9987.13961